全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

JAK-STAT Lodges in Multiple Sclerosis: Pathophysiology and Therapeutic Approach Overview

DOI: 10.4236/oalib.1103492, PP. 1-15

Subject Areas: Immunology, Neuroscience, Neurology

Keywords: Cytokines, Janus Kinases, Multiple Sclerosis, Neurogenesis, Signal Transduction, Transcription Factors

Full-Text   Cite this paper   Add to My Lib

Abstract

Multiple sclerosis (MS) is a complex inflammatory and demyelinating disease of central nervous system (CNS). The disease pathogenesis is not fully understood and no actual cure for the disease yet. The disease has genetic and environmental cause as fundamental factors which are identified for the disease pathogenesis so far. One of the characteristic features of the disease is inflammation cause due to activation of pro-inflammatory cells. Interference in signalling pathways such as JAK/STAT could result in physiological or pathological outcome in MS. Dysregulation of JAK/STAT signalling pathway is associated with chronic inflammatory process and immune disorders. In this review, considering the important role of JAK/STAT pathway in signal transduction of inflammatory process and immune responses in CNS, we describe the involvement of this signal transduction pathway in MS. Moreover, we consider the physiological and pathological involvement of JAK/STAT rout in neurogenesis/gliogenesis, cytokines production and as therapeutics target for managing MS.

Cite this paper

Hamid, K. M. , Isiyaku, A. , Kalgo, M. U. , Yahaya, I. S. and Mirshafiey, A. (2017). JAK-STAT Lodges in Multiple Sclerosis: Pathophysiology and Therapeutic Approach Overview. Open Access Library Journal, 4, e3492. doi: http://dx.doi.org/10.4236/oalib.1103492.

References

[1]  Hernández-Pedro, N.Y., Espinosa-Ramirez, G., Pérez de la Cruz, V., Pineda, B. and Sotelo, J. (2013) Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response. Clinical and Developmental Immunology, 2013, Article ID: 413465.
[2]  Olek, M.J. (2011) Epidemiology, Risk Factors and Clinical Features of Multiple Sclerosis in Adults.
www.uptodate.com/contents/epidemiology-and-clinical-
features-of-multiple-sclerosis-in-adults

[3]  Stadelmann, C. (2011) Multiple Sclerosis as a Neurodegenerative Disease: Pathology, Mechanisms and Therapeutic Implications. Current Opinion in Neurology, 24, 224-229.
https://doi.org/10.1097/WCO.0b013e328346056f
[4]  Oksenberg, J.R., Baranzini, S.E., Sawcer, S. and Hauser, S.L. (2008) The Genetics of Multiple Sclerosis: SNPs to Pathways to Pathogenesis. Nature Reviews Genetics, 9, 516-526.
https://doi.org/10.1038/nrg2395
[5]  Compston, A. and Coles, A. (2008) Multiple Sclerosis. The Lancet, 372, 1502-1517.
https://doi.org/10.1016/S0140-6736(08)61620-7
[6]  Vosoughi, R. and Freedman, M.S. (2010) Therapy of MS. Clinical Neurology and Neurosurgery, 112, 365-385.
https://doi.org/10.1016/j.clineuro.2010.03.010
[7]  Martins, T.B., Rose, J.W., Jaskowski, T.D, Wilson, A.R., Husebye, D. and Seraj, H.S. (2011) Analysis of Proinflammatory and Anti-Inflammatory Cytokine Serum Concentrations in Patients with Multiple Sclerosis by Using a Multiplexed Immunoassay. American Journal of Clinical Pathology, 136, 696-704.
https://doi.org/10.1309/AJCP7UBK8IBVMVNR
[8]  Batoulis, H., Addicks, K. and Kuerten, S. (2010) Emerging Concepts in Autoimmune Encephalomyelitis beyond the CD4/TH1 Paradigm. Annals of Anatomy, 192, 179-193.
[9]  Ramagopalan, S.V., Dobson, R., Meier, U.C. and Giovannoni, G. (2010) Multiple Sclerosis: Risk Factors, Prodromes and Potential Causal Pathways. The Lancet Neurology, 9, 727-739.
https://doi.org/10.1016/S1474-4422(10)70094-6
[10]  Romme, C.J., Bornsen, L., Hesse, D., Krakauer, M. Sorensen, P.S. and Sondergaard, H.B. (2012) Cellular Sources of Dysregulated Cytokines in Relapsing-Remitting Multiple Sclerosis. Journal of Neuroinflammation, 9, 215.
[11]  Kasper, L.H. and Shoemaker, J. (2010) Multiple Sclerosis Immunology: The Healthy Immune System vs the Multiple Sclerosis Immune System. Neurology, 74, S2-S8.
https://doi.org/10.1212/WNL.0b013e3181c97c8f
[12]  Rodgers, J.M. and Miller, S.D. (2012) Cytokine Control of Inflammation and Repair in the Pathology of Multiple Sclerosis. Yale Journal of Biology and Medicine, 85, 447-468.
[13]  Nicolas, C.S., Amici, M., Bortolotto, Z.A., Doherty, A., Csaba, Z., Fafouri, A., Dournaud, P., Gressens, P., Collingridge, G.L. and Peineau, S. (2013) The Role of JAK-STAT Signaling within the Central Nervous System. JAK-STAT, 2, e22925.
https://doi.org/10.4161/jkst.22925
[14]  Furqan, M., Mukhi, N., Lee, B. and Liu, D. (2013) Dysregulation of JAK-STAT pathway in Hematological Malignancies and JAK Inhibitors for Clinical Application. Biomarker Research, 1, 5.
https://doi.org/10.1186/2050-7771-1-5
[15]  Harrison, D.A. (2012) The JAK/STAT Pathway. Cold Spring Harbor Perspectives in Biology, 4, pii:a011205.
https://doi.org/10.1101/cshperspect.a011205
[16]  Campbell, I.L. (2005) Cytokine-Mediated Inflammation, Tumorogenesis, and Disease-Associated JAK/STAT/SOCS Signaling Circuits in the Central Nervous System. Brain Research Reviews, 48, 166-177.
[17]  Seavey, M.M. and Dobrzanski, P. (2012) The Many Faces of Janus Kinase. Biochemical Pharmacology, 83, 1136-1145.
[18]  O’Sullivan, L.A., Liongue, C., Lewis, R.S., Stephenson, S.E. and Ward, A.C. (2007) Cytokine Receptor Signaling through the Jak-Stat-Socs Pathway in Disease. Molecular Immunology, 44, 2497-2506.
[19]  Mohr, A., Chatain, N., Domoszlai, T., Rinis, N., Sommerauer, M., Vogt, M. and Müller-Newen, G. (2012) Dynamics and Non-Canonical Aspects of JAK/STAT Signalling. European Journal of Cell Biology, 91, 524-532.
[20]  Zhuang, S. (2013) Regulation of STAT Signaling by Acetylation. Cell Signal, 25, 1924-1931.
[21]  Santos, C.I. and Costa-Pereira, A.P. (2011) Signal Transducers and Activators of Transcription—From Cytokine Signalling to Cancer Biology. Biochimica et Biophysica Acta, 1816, 38-49.
[22]  Benveniste, E.N., Liu, Y., McFarland, B.C. and Qin, H. (2014) Involvement of the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway in Multiple Sclerosis and the Animal Model of Experimental Autoimmune Encephalomyelitis. Journal of Interferon and Cytokine Research, 34, 577-588.
https://doi.org/10.1089/jir.2014.0012
[23]  Levy, D.E. and Darnell, J.J. (2002) Stats: Transcriptional Control and Biological Impact. Nature Reviews Molecular Cell Biology, 3, 651-662.
https://doi.org/10.1038/nrm909
[24]  O’Shea, J.J. and Plenge, R. (2012) JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease. Immunity, 36, 542-550.
https://doi.org/10.1016/j.immuni.2012.03.014
[25]  Cao, F., Hata, R., Zhu, P., Nakashiro, K. and Sakanaka, M. (2010) Conditional Deletion of STAT3 Promotes Neurogenesis and Inhibits Astrogliogenesis in Neural Stem Cells. Biochemical and Biophysical Research Communications, 394, 843-847.
[26]  He, F., Ge, W., Martinowich, K., Becker-Catania, S., Coskun, V., Zhu, W., Wu, H., Castro, D., Guillemot, F., Fan, G., de Vellis, J. and Sun, Y.E. (2005) A Positive Autoregulatory Loop of JAK-STAT Signaling Controls the Onset of Astrogliogenesis. Nature Neuroscience, 8, 616-625.
https://doi.org/10.1038/nn1440
[27]  de la Iglesia, N., Puram, S.V. and Bonni, A. (2009) STAT3 Regulation of Glioblastoma Pathogenesis. Current Molecular Medicine, 9, 580-590.
https://doi.org/10.2174/156652409788488739
[28]  Herrmann, J.E., Imura, T., Song, B., Qi, J., Ao, Y., Nguyen, T.K., Korsak, R.A., Takeda, K., Akira, S. and Sofroniew, M.V. (2008) STAT3 Is a Critical Regulator of Astrogliosis and Scar Formation After Spinal Cord Injury. Journal of Neuroscience, 28, 7231-7243.
https://doi.org/10.1523/JNEUROSCI.1709-08.2008
[29]  Wells, J.A. and de Vos, A.M. (1996) Hematopoietic Receptor Complexes. Annual Review of Biochemistry, 65, 609-634.
https://doi.org/10.1146/annurev.bi.65.070196.003141
[30]  Schindler, C., Levy, D.E. and Decker, T. (2007) JAK-STAT Signaling: From Interferons to Cytokines. Journal of Biological Chemistry, 282, 20059-20063.
[31]  Kisseleva, T., Bhattacharya, S., Braunstein, J. and Schindler, C.W. (2002) Signaling through the JAK/STAT Pathway, Recent Advances and Future Challenges. Gene, 285, 1-24.
[32]  Srivastava, P., Mujtaba, M.A. and Singhal, M. (2012) Gene and Cytokines Expression of Multiple Sclerosis and Its Therapeutic Regimen: A Systemic Review. International Journal of Drug Development and Research, 4, 55-66.
[33]  Valentino, L. and Pierre, J. (2006) JAK/STAT Signal Transduction: Regulators and Implication in Hematological Malignancies. Biochemical Pharmacology, 71, 713- 721.
[34]  Egwuagu, C.E. (2009) STAT3 in CD4 T helper Cell Differentiation and Inflammatory Diseases. Cytokine, 47, 149-156.
[35]  Vera, J., Rateitschak, K., Lange, F., Kossow, C., Wolkenhauer, O. and Jaster, R. (2011) Systems Biology of JAK-STAT Signalling in Human Malignancies. Progress in Biophysics and Molecular Biology, 106, 426-434.
[36]  Ihle, J.N. (2001) The Stat Family in Cytokine Signaling. Current Opinion in Cell Biology, 13, 211-217.
[37]  Cayre, M., Canoll, P. and Goldman, J.E. (2009) Cell Migration in the Normal and Pathological Postnatal Mammalian Brain. Progress in Neurobiology, 88, 41-63.
[38]  Bauer, S. (2009) Cytokine Control of Adult Neural Stem Cells. Annals of the New York Academy of Sciences, 1153, 48-56.
https://doi.org/10.1111/j.1749-6632.2009.03986.x
[39]  Gómez-Nicola, D., Valle-Argos, B., Pallas-Bazarra, N. and Nieto-Sampedro, M. (2011) Interleukin-15 Regulates Proliferation and Self-Renewal of Adult Neural Stem Cells. Molecular Biology of the Cell, 22, 1960-1970.
https://doi.org/10.1091/mbc.E11-01-0053
[40]  Bonni, A., Sun, Y., Nadal-Vicens, M., Bhatt, A., Frank, D.A., Rozovsky, I., Stahl, N., Yancopoulos, G.D. and Greenberg, M.E. (1997) Regulation of Gliogenesis in the Central Nervous System by the JAK-STAT Signaling Pathway. Science, 278, 477- 483.
https://doi.org/10.1126/science.278.5337.477
[41]  Garza, J.C., Guo, M., Zhang, W. and Lu, X.Y. (2008) Leptin Increases Adult Hippocampal Neurogenesis in Vivo and in Vitro. Journal of Biological Chemistry, 283, 18238-18247.
https://doi.org/10.1074/jbc.M800053200
[42]  Kim, Y.H., Chung, J.I., Woo, H.G., Jung, Y.S., Lee, S.H., Moon, C.H., Suh-Kim, H. and Baik, E.J. (2010) Differential Regulation of Proliferation and Differentiation in Neural Precursor Cells by the JAK Pathway. Stem Cells, 28, 1816-1828.
https://doi.org/10.1002/stem.511
[43]  Müller, S., Chakrapani, B.P., Schwegler, H., Hofmann, H.D. and Kirsch, M. (2009) Neurogenesis in the Dentate Gyrus Depends on Ciliary Neurotrophic Factor and Signal Transducer and Activator of Transcription 3 Signaling. Stem Cells, 27, 431- 441.
https://doi.org/10.1634/stemcells.2008-0234
[44]  Hirsch, M., Knight, J., Tobita, M., Soltys, J., Panitch, H. and Mao-Draayer, Y. (2009) The Effect of Interferon-Beta on Mouse Neural Progenitor Cell Survival and Differentiation. Biochemical and Biophysical Research Communications, 388, 181-186.
[45]  Lum, M., Croze, E., Wagner, C., McLenachan, S., Mitrovic, B. and Turnley, A.M. (2009) Inhibition of Neurosphere Proliferation by IFN-Gamma but Not IFN Beta Is Coupled to Neuronal Differentiation. Journal of Neuroimmunology, 206, 32-38.
https://doi.org/10.1016/j.jneuroim.2008.10.009
[46]  Arscott, W.T., Soltys, J., Knight, J. and Mao-Draayer, Y. (2011) Interferon β-1b Directly Modulates Human Neural Stem/Progenitor Cell Fate. Brain Research, 1413, 1-8.
https://doi.org/10.1016/j.brainres.2011.07.037
[47]  Mangoura, D., Pelletiere, C., Leung, S., Sakellaridis, N. and Wang, D.X. (2000) Prolactin Concurrently Activates Src-PLD and JAK/Stat Signaling Pathways to Induce Proliferation While Promoting Differentiation in Embryonic Astrocytes. International Journal of Developmental Neuroscience, 18, 693-704.
[48]  Gupta, S., Mishra, K., Surolia, A. and Banerjee, K. (2011) Suppressor of Cytokine Signalling-6 Promotes Neurite Outgrowth via JAK2/STAT5-Mediated Signalling Pathway, Involving Negative Feedback Inhibition. PLoS ONE, 6, e26674.
https://doi.org/10.1371/journal.pone.0026674
[49]  M?kel?, J., Koivuniemi, R., Korhonen, L. and Lindholm, D. (2010) Interferon- Gamma Produced by Microglia and the Neuropeptide PACAP Have Opposite Effects on the Viability of Neural Progenitor Cells. PLoS ONE, 5, e11091.
https://doi.org/10.1371/journal.pone.0011091
[50]  Fontaine, R.H., Cases, O., Lelièvre, V., Mesplès, B., Renauld, J.C., Loron, G., Degos, V., Dournaud, P., Baud, O. and Gressens, P. (2008) IL-9/IL-9 Receptor Signaling Selectively Protects Cortical Neurons against Developmental Apoptosis. Cell Death & Differentiation, 15, 1542-1552.
https://doi.org/10.1038/cdd.2008.79
[51]  Schwaiger, F.W., Hager, G., Schmitt, A.B., Horvat, A., Hager, G., Streif, R., Spitzer, C., Gamal, S., Breuer, S., Brook, G.A., Nacimiento, W. and Kreutzberg, G.W. (2000) Peripheral but Not Central Axotomy Induces Changes in Janus Kinases (JAK) and Signal Transducers and Activators of Transcription (STAT). European Journal of Neuroscience, 12, 1165-1176. https://doi.org/10.1046/j.1460-9568.2000.00005.x
[52]  Smith, P.D., Sun, F., Park, K.K., Cai, B., Wang, C., Kuwako, K., Martinez-Carrasco, I., Connolly, L. and He, Z. (2009) SOCS3 Deletion Promotes Optic Nerve Regeneration in Vivo. Neuron, 64, 617-623. https://doi.org/10.1016/j.neuron.2009.11.021
[53]  Qiu, J., Cafferty, W.B., McMahon, S.B. and Thompson, S.W. (2005) Conditioning Injury-Induced Spinal Axon Regeneration Requires Signal Transducer and Activator of Transcription 3 Activation. Journal of Neuroscience, 25, 1645-1653.
https://doi.org/10.1523/JNEUROSCI.3269-04.2005
[54]  Greve, B., Weissert, R., Hamdi, N., Bettelli, E., Sobel, R.A., Coyle, A., Kuchroo, V.K., Rajewsky, K. and Schmidt-Supprian, M. (2007) IκB Kinase 2/β Deficiency Controls Expansion of Autoreactive T Cells and Suppresses Experimental Autoimmune Encephalomyelitis. Journal of Immunology, 179, 179-185.
https://doi.org/10.4049/jimmunol.179.1.179
[55]  Nishikomori, R., Usui, T., Wu, C.Y., Morinobu, A., O’Shea, J.J. and Strober, W. (2002) Activated STAT4 Has an Essential Role in Th1 Differentiation and Proliferation That Is Independent of Its Role in the Maintenance of IL-12R Beta 2 Chain Expression and Signaling. Journal of Immunology, 169, 4388-4398.
https://doi.org/10.4049/jimmunol.169.8.4388
[56]  Nishibori, T., Tanabe, Y., Su, L. and David, M. (2004) Impaired Development of CD4 CD25 Regulatory T Cells in the Absence of STAT1: Increased Susceptibility to Autoimmune Disease. Journal of Experimental Medicine, 199, 25-34.
https://doi.org/10.1084/jem.20020509
[57]  Liu, X., Lee, Y.S., Yu, C.R. and Egwuagu, C.E. (2008) Loss of STAT3 in CD4 T Cells Prevents Development of Experimental Autoimmune Diseases. Journal of Immunology, 180, 6070-6076.
https://doi.org/10.4049/jimmunol.180.9.6070
[58]  Liao, W., Lin, J.X., Wang, L., Li, P. and Leonard, W.J. (2011) Modulation of Cytokine Receptors by IL-2 Broadly Regulates Differentiation into Helper T Cell Lineages. Nature Immunology, 12, 551-559.
https://doi.org/10.1038/ni.2030
[59]  Stritesky, G.L., Muthukrishnan, R., Sehra, S., Goswami, R., Pham, D., Travers, J., Nguyen, E.T., Levy, D.E. and Kaplan, M.H. (2011) The Transcription Factor STAT3 Is Required for T Helper 2 Cell Development. Immunity, 34 39-49.
https://doi.org/10.1016/j.immuni.2010.12.013
[60]  Carpentier, P.A., Duncan, D.S. and Miller, S.D. (2008) Glial Toll-Like Receptor Signaling in Central Nervous System Infection and Autoimmunity. Brain, Behavior, and Immunity, 22, 140-147.
https://doi.org/10.1016/j.bbi.2007.08.011
[61]  Flavell, R.A., Sanjabi, S., Wrzesinski, S.H. and Licona-Limon, P. (2010) The Polarization of Immune Cells in the Tumour Environment by TGF Beta. Nature Review Immunology, 10, 554-567.
https://doi.org/10.1038/nri2808
[62]  Cao, L. and He, C. (2013) Polarization of Macrophages and Microglia in Inflammatory Demyelination. Neuroscience Bulletin, 29, 189-198.
https://doi.org/10.1007/s12264-013-1324-0
[63]  Lawrence, T. and Natoli, G. (2011) Transcriptional Regulation of Macrophage Polarization: Enabling Diversity with Identity. Nature Review Immunology, 11, 750-761.
https://doi.org/10.1038/nri3088
[64]  Mansilla, M.J., Montalban, X. and Espejo, C. (2012) Heat Shock Protein 70: Roles in Multiple Sclerosis. Molecular Medicine, 18, 1018-1028.
[65]  Jiang, Z., Li, H., Fitzgerald, D.C., Zhang, G.Z. and Rostami, A. (2009) MOG35-55 i.v Suppresses Experimental Autoimmune Encephalomyelitis Partially through Modulation of Th17 and JAK/STAT Pathways. European Journal of Immunology, 39, 789-799.
https://doi.org/10.1002/eji.200838427
[66]  Boyton, R.J., Davies, S., Marden, C., Fantino, C., Reynolds, C., Portugal, K, Dewchand, H. and Altmann, D.M. (2005) Stat4-Null Non-Obese Diabetic Mice: Protection from Diabetes and Experimental Allergic Encephalomyelitis, but with Concomitant Epitope Spread. International Immunology, 17, 1157-1165.
https://doi.org/10.1093/intimm/dxh293
[67]  Bettelli, E., Korn, T. and Kuchroo, V.K. (2007) Th17: The Third Member of the Effector T Cell Trilogy. Current Opinion in Immunology, 19, 652-657.
https://doi.org/10.1016/j.coi.2007.07.020
[68]  Jadidi-Niaragh, F. and Mirshafiey, A. (2011) Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis. Scandinavian Journal of Immunology, 74, 1-13.
https://doi.org/10.1111/j.1365-3083.2011.02536.x
[69]  Iwakura, Y. and Ishigame, H. (2006) The IL-23/IL-17 Axis in Inflammation. Journal of Clinical Investigation, 116, 1218-1222.
https://doi.org/10.1172/JCI28508
[70]  Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H.J., Waisman, A. and Kuhlmann, C.R. (2010) Cellular Mechanisms of IL-17-Induced Blood-Brain Barrier Disruption. FASEB Journal, 24, 1023-1034.
https://doi.org/10.1096/fj.09-141978
[71]  Tzartos, J.S., Friese, M.A., Craner, M.J., Palace, J., Newcombe, J., Esiri, M.M. and Fugger, L. (2008) Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis. American Journal of Pathology, 172, 146-155.
https://doi.org/10.2353/ajpath.2008.070690
[72]  Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K. and Iwakura, Y. (2006) IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis. Journal of Immunology, 177, 566- 573.
https://doi.org/10.4049/jimmunol.177.1.566
[73]  Fitzgerald, D.C., Ciric, B., Touil, T., Harle, H., Grammatikopolou, J., Das Sarma, J., Gran, B., Zhang, G.X. and Rostami, A. (2007) Suppressive Effect of IL-27 on Encephalitogenic Th17 Cells and the Effector Phase of Experimental Autoimmune Encephalomyelitis. Journal of Immunology, 179, 3268-3275.
https://doi.org/10.4049/jimmunol.179.5.3268
[74]  Stromnes, I.M., Cerretti, L.M., Liggitt, D., Harris, R.A. and Goverman, J.M. (2008) Differential Regulation of Central Nervous System Autoimmunity by TH1 and TH17 Cells. Nature Medicine, 14, 337-342.
https://doi.org/10.1038/nm1715
[75]  Camporeale, A. and Poli, V. (2012) IL-6, IL-17 and STAT3: A Holy Trinity in Auto-Immunity? Frontiers in Bioscience, 17, 2306-2326. https://doi.org/10.2741/4054
[76]  Laurence, A., Tato, C.M., Davidson, T.S., Kanno, Y., Chen, Z., Yao, Z., Blank, R.B., Meylan, F., Siegel, R., Hennighausen, L., Shevach, E.M. and O’Shea, J.J. (2007) Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation. Immunity, 26, 371-381.
https://doi.org/10.1016/j.immuni.2007.02.009
[77]  Yang, X.P., Ghoreschi, K., Steward-Tharp, S.M., Rodriguez-Canales, J., Zhu, J., Grainger, J.R., Hirahara, K., Sun, H.W., Wei, L., Vahedi, G., Kanno, Y., O’Shea, J.J. and Laurence, A. (2011) Opposing Regulation of the Locus Encoding IL-17 through Direct, Reciprocal Actions of STAT3 and STAT5. Nature Immunology, 12, 247-254.
https://doi.org/10.1038/ni.1995
[78]  Durant, L., Watford, W.T., Ramos, H.L., Laurence, A., Vahedi, G., Wei, L., Takahashi, H., Sun, H.W., Kanno, Y., Powrie, F. and O’Shea, J.J. (2010) Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and Homeostasis. Immunity, 32, 605-615.
https://doi.org/10.1016/j.immuni.2010.05.003
[79]  El-Kasmi, K.C., Holst, J., Coffre, M., Mielke, L., de Pauw, A., Lhocine, N., Smith, A.M., Rutschman, R., Kaushal, D., Shen, Y., Suda, T., Donnelly, R.P., Myers Jr., M.G., Alexander, W., Vignali, D.A., Watowich, S.S., Ernst, M., Hilton, D.J. and Murray, P.J. (2006) General Nature of the STAT3-Activated Anti-Inflammatory Response. Journal of Immunology, 177, 7880-7888.
https://doi.org/10.4049/jimmunol.177.11.7880
[80]  Burchill, M.A., Yang, J., Vogtenhuber, C., Blazar, B.R. and Farrar, M.A. (2007) IL-2 Receptor Beta-Dependent STAT5 Activation Is Required for the Development of Foxp3 Regulatory T Cells. Journal of Immunology, 178, 280-290.
https://doi.org/10.4049/jimmunol.178.1.280
[81]  Chen, Y., Haines, C.J., Gutcher, I., Hochweller, K., Blumenschein, W.M., McClanahan, T., H?mmerling, G., Li, M.O., Cua, D.J. and McGeachy, M.J. (2011) Foxp3 Regulatory T Cells Promote T Helper 17 Cell Development in Vivo through Regulation of Interleukin-2. Immunity, 34, 409-421.
https://doi.org/10.1016/j.immuni.2011.02.011
[82]  Pandiyan, P., Conti, H.R., Zheng, L., Peterson, A.C., Mathern, D.R., Hernandez- Santos, N., Edgerton, M., Gaffen, S.L. and Lenardo, M.J. (2011) CD4 CD25 Foxp3 Regulatory T Cells Promote Th17 Cells in Vitro and Enhance Host Resistance in Mouse Candida albicans Th17 Cell Infection Model. Immunity, 34, 422-434.
https://doi.org/10.1016/j.immuni.2011.03.002
[83]  Lin, Y., Wang, F. and Zhang, G.L. (2014) Natural Products and Their Derivatives Regulating the Janus Kinase/Signal Transducer and Activator of Transcription Pathway. Journal of Asian Natural Products and Research, 16, 800-812.
https://doi.org/10.1080/10286020.2014.929573
[84]  Bright, J.J., Du, C. and Sriram, S. (1999) Tyrphostin B42 Inhibits IL12-Induced Tyrosine Phosphorylation and Activation of Janus Kinase-2 and Prevents Experimental Allergic Encephalomyelitis. Journal of Immunology, 162, 6255-6262.
[85]  Liu, Y., Holdbrooks, A.T., De Sarno, P., Rowse, A.L., Yanagisawa, L.L., McFarland, B.C. and Harringt, L.E. (2014) Therapeutic Efficacy of Suppressing the JAK/STAT Pathway in Multiple Models of EAE. Journal of Immunology, 192, 59-72.
https://doi.org/10.4049/jimmunol.1301513
[86]  Ghoreschi, K., Jesson, M.I., Li, X., Lee, J.L., Ghosh, S., Alsup, J.W., Warner, J.D., Tanaka, M., Steward-Tharp, S.M., Gadina, M., Thomas, C.J., Minnerly, J.C., Storer, C.E., LaBranche, T.P., Radi, Z.A., Dowty, M.E., Head, R.D., Meyer, D.M., Kishore, N. and O’Shea, J.J. (2011) Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550). Journal of Immunology, 186, 4234-4243.
https://doi.org/10.4049/jimmunol.1003668
[87]  Van Vollenhoven, R.F., Fleischmann, R., Cohen, S., Lee, E.B., Garcia Meijide, J.A., Wagner, S. Forejtova, S., Zwillich, S.H., Gruben, D., Koncz, T., Wallenstein, G.V., Krishnaswami, S., Bradley, J.D. and Wilkinson, B. (2012) Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis. The New England Journal of Medicine, 367, 508-519.
https://doi.org/10.1056/NEJMoa1112072
[88]  Muthian, G., Raikwar, H.P., Rajasingh, J. and Bright, J.J. (2006) 1,25 Dihydroxyvitamin-D3 Modulates JAK-STAT Pathway in IL-12/IFN Gamma Axis Leading to Th1 Response in Experimental Allergic Encephalomyelitis. Journal of Neuroscience Research, 83, 1299-1309.
https://doi.org/10.1002/jnr.20826
[89]  Qin, X., Guo, B.T., Wan, B., Fang, L., Lu, L., Wu, L., Zang, Y.Q. and Zhang, J.Z. (2010) Regulation of Th1 and Th17 Cell Differentiation and Amelioration of Experimental Autoimmune Encephalomyelitis by Natural Product Compound Berberine. Journal of Immunology, 185, 1855-1863.
https://doi.org/10.4049/jimmunol.0903853
[90]  Jia, Y., Jing, J., Bai, Y., Li, Z., Liu, L., Luo, J., Liu, M. and Chen, H. (2011) Amelioration of Experimental Autoimmune Encephalomyelitis by Plumbagin through Down- Regulation of JAK-STAT and NF-κB Signaling Pathways. PLoS ONE, 6, e27006.
https://doi.org/10.1371/journal.pone.0027006
[91]  Chen, C., Liu, X., Wan, B. and Zhang, J.Z. (2009) Regulatory Properties of Copolymer I in Th17 Differentiation by Altering STAT3 Phosphorylation. Journal of Immunology, 183, 246-253.
[92]  Wang, H., Brown, J., Garcia, C.A., Tang, Y., Benakanakere, M.R., Greenway, T., Pascale, A., Denis, F.K. and Michael, M. (2011). The Role of Glycogen Synthase Kinase 3 in Regulating IFN-Beta-Mediated IL-10 Production. Journal of Immunology, 186, 675-684.
https://doi.org/10.4049/jimmunol.1001473

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413